News from EU-Japan Business Round Table’s member NEC Japan establishes European subsidiaries to strengthen its work on AI drug development
NEC strengthens its European life science activities where AI technology, biomedical science and ICT combine to develop advanced therapies for patients across the globe. Central and Northern Europe’s vivid entrepreneurial and scientific environment, and the European clinical network and regulatory infrastructure, help drive developments in immunotherapies.